Related Experiment Video

Updated: Aug 11, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

In stent restenosis: bane of the stent era

A K Mitra1, D K Agrawal

  • 1Departments of Biomedical Sciences, Medicine, and Medical Microbiology and Immunology, Creighton University School of Medicine, Omaha, NE 68178, USA.

Journal of Clinical Pathology
|March 1, 2006
PubMed

Insights

In-stent restenosis (ISR) involves platelets and macrophages driving neointimal hyperplasia. Understanding ISR

Area of Science:

  • Cardiovascular Research
  • Biomedical Engineering

Background:

  • In-stent restenosis (ISR) significantly impacts long-term outcomes of stent implantation.
  • The precise underlying mechanisms of ISR remain incompletely understood despite identified contributing factors.

Purpose of the Study:

  • To elucidate the complex cellular and molecular mechanisms driving in-stent restenosis.
  • To highlight emerging research areas in antirestenosis therapies.

Main Methods:

  • Review of existing literature on ISR pathogenesis.
  • Analysis of cellular components (platelets, macrophages) and molecular pathways (cytokines, Akt pathway).

Main Results:

  • Platelets and macrophages are central to ISR via vascular smooth muscle cell migration and proliferation, leading to neointimal hyperplasia.
  • Extracellular matrix formation constitutes the bulk of neointimal hyperplasia.
  • Inflammatory cytokines, suppressors of cytokine signalling, and mechanical stretch-induced Akt pathway activation are implicated in ISR.

Conclusions:

  • ISR is a multifactorial process involving intricate cellular and molecular interactions.
  • Effective prevention requires a multifaceted therapeutic approach, as no single 'magic bullet' exists.

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...